Santen Pharmaceutical Co Ltd (4536) – Strategy, SWOT and Corporate Finance Report

Santen Pharmaceutical Co Ltd (4536) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacturing and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for glaucoma, bacterial conjunctivitis, dry eye, inflammation, cataract, muscae volitantes, diabetic retinopathy, retinal detachment, hyposphagma, myopia, retinal detachment, amblyopia, astigmatism, strabismus, hordeolum, VDT syndrome, and others; over-the-counter products ophthalmic products; anti-allergy ophthalmic products; and medical devices such as intraocular lenses (IOLs) and other ophthalmic products. Santen operates through its group companies located in Asia, Europe and the US. It operates production facilities in Noto, and Shiga, Japan; and Suzhou, China. Santen is headquartered in Kita-ku, Osaka, Japan.

Scope

• Detailed information on Santen Pharmaceutical Co Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Santen Pharmaceutical Co Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Santen Pharmaceutical Co Ltd including a breakdown and examination of key business segments

• News about Santen Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Santen Pharmaceutical Co Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Santen Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Santen Pharmaceutical Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Rohto Pharmaceutical Co Ltd

Senju Pharmaceutical Co Ltd

Astellas Pharma Inc

Aqumen Biopharmaceuticals

Mitsubishi Tanabe Pharma Corp

Chugai Pharmaceutical Co Ltd

Taisho Pharmaceutical Holdings Co Ltd

Daiichi Sankyo Co Ltd

Hoya Corp

Mitsubishi Tanabe Pharma Corp

Astellas Pharma Inc

Aqumen Biopharmaceuticals

Alcon Japan Ltd

Daiichi Sankyo Co Ltd

Hoya Corp

Rohto Pharmaceutical Co Ltd

Senju Pharmaceutical Co Ltd

Chugai Pharmaceutical Co Ltd

Taisho Pharmaceutical Holdings Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Santen Pharmaceutical Co Ltd - Key Facts

Santen Pharmaceutical Co Ltd - Key Employees

Santen Pharmaceutical Co Ltd - Key Employee Biographies

Santen Pharmaceutical Co Ltd - Major Products and Services

Santen Pharmaceutical Co Ltd - History

Santen Pharmaceutical Co Ltd - Company Statement

Santen Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Santen Pharmaceutical Co Ltd - Business Description

Product Category: Medical Devices

Performance

Product Category: OTC Pharmaceuticals

Performance

Product Category: Others

Performance

Product Category: Prescription Pharmaceuticals

Performance

Geographical Segment: Americas

Performance

Geographical Segment: Asia

Performance

Geographical Segment: China

Performance

Geographical Segment: EMEA

Performance

Geographical Segment: Japan

Performance

R&D Overview

Santen Pharmaceutical Co Ltd - Corporate Strategy

Santen Pharmaceutical Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Santen Pharmaceutical Co Ltd - Strengths

Santen Pharmaceutical Co Ltd - Weaknesses

Santen Pharmaceutical Co Ltd - Opportunities

Santen Pharmaceutical Co Ltd - Threats

Santen Pharmaceutical Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Santen Pharmaceutical Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Mar 01, 2023: Santen Pharmaceutical: Notice of Corporate Officer Change

Nov 29, 2022: Santen Pharmaceutical: Notice of Personnel Changes

Oct 26, 2022: Santen strengthens global product supply base with completion of third building on site of Shiga product supply center

Oct 14, 2022: Santen Publishes its Annual Integrated Report “Santen Report 2022”

Oct 06, 2022: Santen announces Health Canada approval for Cationorm Plus to relieve the symptoms of dry eye and ocular allergy

Sep 12, 2022: Santen Announces Change of Representative Director of the Board (change in CEO)

Sep 12, 2022: Santen Pharmaceutical: Notice of Personnel Change, Sep 2022

Mar 23, 2022: Santen Pharmaceutical Announces Change of Representative Director of the Board

Mar 02, 2022: Santen wins award for excellence at the “Nikkei Integrated Report Award 2021”

Feb 22, 2022: Reinventing of our leadership team to shape the future of Santen

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Santen Pharmaceutical Co Ltd, Key Facts

Santen Pharmaceutical Co Ltd, Key Employees

Santen Pharmaceutical Co Ltd, Key Employee Biographies

Santen Pharmaceutical Co Ltd, Major Products and Services

Santen Pharmaceutical Co Ltd, History

Santen Pharmaceutical Co Ltd, Other Locations

Santen Pharmaceutical Co Ltd, Subsidiaries

Santen Pharmaceutical Co Ltd, Key Competitors

Santen Pharmaceutical Co Ltd, Ratios based on current share price

Santen Pharmaceutical Co Ltd, Annual Ratios

Santen Pharmaceutical Co Ltd, Annual Ratios (Cont…1)

Santen Pharmaceutical Co Ltd, Annual Ratios (Cont…2)

Santen Pharmaceutical Co Ltd, Interim Ratios

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Santen Pharmaceutical Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Santen Pharmaceutical Co Ltd, Performance Chart (2019 – 2023)

Santen Pharmaceutical Co Ltd, Ratio Charts

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports